Qiagen QGEN
NYSE QGEN
$46.56 +0.43 (+0.93%)
As of: Oct 19, 2026 · 3:59 PM EDT

Qiagen (QGEN) Cash from Restructuring (2019)

Updated

Qiagen (QGEN) reported Cash from Restructuring of $16.91 million for the year ended Dec 31, 2012, down 60.7% from $43.03 million a year earlier.

Analysis

Qiagen (QGEN) Cash from Restructuring (2019) Analysis & Trends

  • Cash from Restructuring has a three-year compound annual growth rate of 19.0% (years ended Dec 2009 to Dec 2012).
  • The figure for the year ended Dec 31, 2012 ranks as the lowest annual Cash from Restructuring since the year ended Dec 31, 2009.
  • According to Business Quant data, Cash from Restructuring came in at $43.03 million in the year ended Dec 31, 2011 and $10.03 million in the year ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn
10 Qiagen 10.11 Bn 5.88 Bn 340.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 27.20 Mn
API Access

Qiagen Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=QGEN&period=max&api_key=YOUR_API_KEY